Del 17p
Deletion of 17p13 (TP53). High-risk feature in CLL and multiple myeloma; predicts resistance to chemotherapy.
No Drugs found for this biomarker.
Deletion of 17p13 (TP53). High-risk feature in CLL and multiple myeloma; predicts resistance to chemotherapy.
No Drugs found for this biomarker.